食品科学 ›› 2022, Vol. 43 ›› Issue (21): 117-125.doi: 10.7506/spkx1002-6630-20210917-210

• 营养卫生 • 上一篇    

一种基于BALB/c背景由膳食麸质引起的乳糜泻小鼠模型的构建及其评价

宋东筱,任正楠,潘礼龙,孙嘉   

  1. (1.江南大学食品学院,江苏 无锡 214122;2.江南大学无锡医学院,江苏 无锡 214122)
  • 发布日期:2022-12-12
  • 基金资助:
    国家自然科学基金优秀青年科学基金项目(8212200709);江苏省杰出青年基金资助项目(BK20200026)

Establishment and Evaluation of a BALB/c Mouse Model of Celiac Disease Caused by Dietary Gluten

SONG Dongxiao, REN Zhengnan, PAN Lilong, SUN Jia   

  1. (1. School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; 2. Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China)
  • Published:2022-12-12

摘要: 目的:利用麸质诱导建立小鼠乳糜泻(celiac disease,CeD)模型,通过检测乳糜泻相关指标来评价该模型的可行性。方法:将连续食用无麸质饲料3 代以上的雌性BALB/c小鼠(6~8 周龄)随机分为两组(对照组(Control组)和模型组(CeD组)),CeD组于实验开始的第1天将饲料换为麸质含量2.5 g/kg的含麸质饲料,Control组则继续饲喂无麸质饲料。实验前3 周,分别给予CeD组每只小鼠腹腔注射含150 μg麦醇溶蛋白的磷酸盐缓冲溶液(0.2 mL 0.01 mol/L),每周两次。在实验的第4周,给予CeD组每只小鼠后脚掌注射乳化有50 μg麦醇溶蛋白的弗氏完全佐剂50 μL两次(第1天和第4天各注射一次)。利用血清荧光素异硫氰酸酯-葡聚糖质量浓度表征小鼠的肠道通透性;利用实时荧光定量聚合酶链式反应检测小鼠十二指肠组织中紧密连接蛋白(ZO-1、ZO-2、Claudin-1等)、相关炎症因子白细胞介素((interleukin,IL)-15、干扰素(interferon,IFN)γ和IL-4等)和相关免疫细胞的表面标志物基因(CD4、CD19、CD138等)的表达水平;采用酶联免疫吸附试验测定小鼠十二指肠中组织转谷氨酰胺酶(tissue transglutaminase,tTG)和连接蛋白水平。结果:相比Control组,CeD组小鼠十二指肠肠道屏障被明显破坏,小肠绒毛长度明显缩短,TGM2 mRNA相对表达量显著升高(P<0.05),与乳糜泻相关的炎症因子和免疫细胞的标志物基因相对表达量都显著升高。结论:该造模方法在肠道病理情况、肠道屏障以及免疫方面均能很好地模拟临床上乳糜泻的病理学特征,可用于未来乳糜泻新的潜在治疗措施研究中。

关键词: 乳糜泻;麸质;动物模型

Abstract: Objective: A mouse model of celiac disease induced by gluten was established and its feasibility was evaluated by testing diagnostic indicators of celiac disease. Methods: Female BALB/c mice aged 6–8 weeks fed a gluten-free diet for more than three generations were randomly divided into two groups, control and celiac disease (CeD). On the first day of the experiment, the mice in the CeD group were fed a gluten-containing diet (2.5 g/kg) instead of the gluten-free diet for 30 days while those in the control group were still fed the gluten-free diet. In the first three weeks, each mouse in the CeD group was intraperitoneally injected with 0.2 mL of 0.01 mol/L phosphate buffered saline containing 150 μg of gliadin twice a week. In the fourth week, the rear footpad of each mouse in this group was injected twice with 50 μg of gliadin emulsified in 50 μL of Freund’s complete adjuvant (on the first and fourth days respectively). Fluorescein isothiocyanate-labeled dextran levels were used to indicate intestinal permeability in mice; real-time quantitative polymerase chain reaction (qPCR) was used to detect the expression of tight junction proteins (ZO-1, ZO-2 and claudin-1), inflammatory cytokines (interleukin (IL)-15, IFN-γ and IL-4) and immune cell marker genes (CD4, CD19 and CD138) in the duodenum; and the enzyme-linked immunosorbent assay (ELISA) was used to measure the levels of total transglutaminase (tTG) and zonulin in duodenal tissue. Results: The intestinal barrier of the mice in the CeD group was damaged, the length of small intestinal villi was significantly decreased, the mRNA expression of the gene encoding transglutaminase 2 (TG2) was significantly increased (P < 0.05), and the relative expression levels of genes encoding cytokines and immune cell markers associated with celiac disease were notably increased compared with the control group. Conclusion: The animal model can effectively mimic the key clinical features of celiac disease as evidenced by intestinal pathology, intestinal barrier, and immune response. It may be used in future research to develop potential therapeutics for celiac disease.

Key words: celiac disease; gluten; animal models

中图分类号: